• Explore /
  • Poster
  • / Central nervous system efficacy of furmonertinib versus gefitinib in patients with non–small cell lung cancer with epidermal growth factor receptor mutations: Results from FURLONG study.

Central nervous system efficacy of furmonertinib versus gefitinib in patients with non–small cell lung cancer with epidermal growth factor receptor mutations: Results from FURLONG study.

Abstract Poster

Authors

null

Gongyan Chen

Department of Respiration, Harbin Medical University Cancer Hospital, Harbin, China

Gongyan Chen , Xiang Wang , Yunpeng Liu , Lin Wu , Yanrong Hao , Chunling Liu , Shuyang Zhu , Xiaodong Zhang , Yuping Li , Jiwei Liu , Lejie Cao , Ying Cheng , Hui Zhao , Shucai Zhang , Aimin Zang , Jiuwei Cui , Jian Feng , Fei Liu , Chuan Gu , Yuankai Shi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03787992

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9101)

DOI

10.1200/JCO.2022.40.16_suppl.9101

Abstract #

9101

Poster Bd #

88

Abstract Disclosures

Similar Posters

First Author: Nobuaki Mamesaya

First Author: Helena Alexandra Yu

First Author: Haiyang Chen

First Author: Yan Xu